LabCompass

Huangbing Wu

Medicine · Indiana University

OpenAlex
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentInflammatory mediators and NSAID effectsAngiogenesis and VEGF in CancerNeuroendocrine Tumor Research Advances

Publications

35

Citations

874

Est. group size

—

Recurring co-author estimate

Active years

29

Publishing since 1997

Research summary
AI-generated

Huangbing Wu works in medicine, with a research record touching on cancers of the pancreas and liver, pancreatitis, and the role of blood-vessel growth (angiogenesis) and inflammation in disease. The work spans oncology and the biological processes that drive tumor growth and tissue inflammation.

Pancreatic and liver cancerPancreatitisInflammation and NSAID effectsTumor angiogenesis (VEGF)Neuroendocrine tumors

Publication activity has slowed over the last decade, moving from about five papers per year in 2017 and 2019 to roughly one or fewer in recent years (averaging 0.8 per year over the last five years).

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.8/year recently
2017: 5 publications5172018: 2 publications182019: 5 publications5192020: 2 publications202021: 1 publication212022: 1 publication222023: 1 publication23242025: 2 publications2526
Recent publications

No publications ingested yet.

Publishes in
  • Journal of the American College of Surgeons×3
  • The American Journal of Surgery×2
  • Pancreas×2
  • Cancer Research×2
  • Surgery×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile